SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-22-016439
Filing Date
2022-04-28
Accepted
2022-04-28 16:07:30
Documents
4
Period of Report
2022-06-01

Document Format Files

Seq Description Document Type Size
1 DEF 14A xene-def14a_20220601.htm DEF 14A 2044214
2 GRAPHIC gabfnexkl2zs000003.jpg GRAPHIC 2745
3 GRAPHIC gabfnexkl2zs000001.jpg GRAPHIC 27464
4 GRAPHIC gabfnexkl2zs000002.jpg GRAPHIC 27464
  Complete submission text file 0001564590-22-016439.txt   2125079
Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Filer) CIK: 0001582313 (see all company filings)

IRS No.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36687 | Film No.: 22866532
SIC: 2834 Pharmaceutical Preparations